Avid Logo June 2022.jpg
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022
November 29, 2022 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
vmr logo registered_ blue.png
Viral Vector Manufacturing Market is expected to generate a revenue of USD 1,733.42 Million by 2028, Globally, at 19.1% CAGR: Verified Market Research®
November 18, 2022 09:15 ET | Verified Market Research
Jersey City, New Jersey, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Viral Vector Manufacturing Market” By Type (Retroviral Vectors, Adenoviral Vectors,...
22157.jpg
Biologics Outsourcing Global Market Report 2022: Increased Therapeutic Value and Huge Potential of Biologics Outsourcing Boosts Sector
November 14, 2022 04:28 ET | Research and Markets
Dublin, Nov. 14, 2022 (GLOBE NEWSWIRE) -- The "Biologics Outsourcing Global Market - Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The biologics outsourcing global...
22157.jpg
Global Exosome-Mediated Drug Delivery Technology Market Research Report 2022: Exosomes Are Promising Delivery Carriers for Advanced Therapeutics
November 07, 2022 07:48 ET | Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Technology Growth Opportunities for Exosome-Mediated Drug Delivery" report has been added to ResearchAndMarkets.com's offering. This research...
22157.jpg
Biopharmaceutical Contract Manufacturing Market, 2035 - Shift from One-time Contracts to Strategic Partnerships
October 19, 2022 05:28 ET | Research and Markets
Dublin, Oct. 19, 2022 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of...
22157.jpg
Worldwide AAV Vector Industry Report 2022 - by Type of Therapy, Type of Gene Delivery Method Used, Target Therapeutic Area, Application Area, Scale of Operation and Geographical Regions
October 17, 2022 07:08 ET | Research and Markets
Dublin, Oct. 17, 2022 (GLOBE NEWSWIRE) -- The "AAV Vector Market: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering. This report features...
22157.jpg
Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Report 2022: Increasing Number of Cell & Gene Therapies Priming Sector for Substantial Growth
October 06, 2022 05:23 ET | Research and Markets
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application...
Global Cell Therapy Market
Outlook on the Cell Therapy Global Market to 2028 - Increased Demand for Novel, Better Medicines for Diseases Such as Cancer and CVD Has Resulted in an Increase in General Research Efforts
October 05, 2022 07:08 ET | Research and Markets
Dublin, Oct. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market, By Use Type, By Therapy Type, By Product, By Technology & By Region- Forecast and Analysis 2022-2028" report has been...
Global Transfection Technologies Market
Outlook on the Transfection Technologies Global Market to 2027 - Increasing Prevalence of Cancer and Various Chronic Lifestyle Diseases is Driving Growth
September 28, 2022 04:28 ET | Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Avid Logo June 2022.jpg
Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations
September 22, 2022 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...